Showing results (1151-1160 of 1,165) with videos related to

Sort By:
Pageof 117
JACC. Heart Failure|July 11, 2021
NT-proBNP for Risk Prediction in Heart Failure: Identification of Optimal Cutoffs Across Body Mass Index CategoriesGiuseppe Vergaro, Francesco Gentile, Laura M G Meems, et al.
Ophthalmology|April 18, 2022
High-risk Pathologic Features Based on Presenting Findings in Advanced Intraocular Retinoblastoma: A Multicenter, International Data-Sharing American Joint Committee on Cancer StudyAnkit Singh Tomar, Paul T Finger, Brenda Gallie, et al.
Ophthalmology|May 2, 2022
Metastatic Death Based on Presenting Features and Treatment for Advanced Intraocular Retinoblastoma: A Multicenter Registry-Based StudyAnkit Singh Tomar, Paul T Finger, Brenda Gallie, et al.
ESC Heart Failure|May 5, 2022
Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failureGiuseppe Vergaro, Francesco Gentile, Alberto Aimo, et al.
The British Journal of Ophthalmology|August 3, 2021
Retinoblastoma seeds: impact on American Joint Committee on Cancer clinical stagingAnkit Singh Tomar, Paul T Finger, Brenda Gallie, et al.
The Journal of Experimental Medicine|July 12, 2017
Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life spanAlexander V Misharin, Luisa Morales-Nebreda, Paul A Reyfman, et al.
The New England Journal of Medicine|August 26, 2022
Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection FractionScott D Solomon, John J V McMurray, Brian Claggett, et al.
American Journal of Respiratory and Critical Care Medicine|December 18, 2018
Single-Cell Transcriptomic Analysis of Human Lung Provides Insights into the Pathobiology of Pulmonary FibrosisPaul A Reyfman, James M Walter, Nikita Joshi, et al.
European Journal of Heart Failure|May 11, 2024
Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trialScott D Solomon, John W Ostrominski, Muthiah Vaduganathan, et al.
The New England Journal of Medicine|September 3, 2024
Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection FractionScott D Solomon, John J V McMurray, Muthiah Vaduganathan, et al.
Pageof 117